Evidence map›Paper›PMID 41097100›Full record

ArticleInternational journal of molecular sciences2025

Antiproliferative and Proapoptotic Effects of Chetomin in Human Melanoma Cells.

Laura Jonderko, Anna Choromańska

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Laura JonderkoDepartment of Molecular and Cellular Biology, Faculty of Pharmacy, Wroclaw Medical University, Borowska 211, 50-556 Wroclaw, Poland.ORCID 0009-0007-6018-121X
Anna ChoromańskaDepartment of Molecular and Cellular Biology, Faculty of Pharmacy, Wroclaw Medical University, Borowska 211, 50-556 Wroclaw, Poland.ORCID 0000-0001-9997-7783

Funding

Department of Molecular and Cellular Biology of Wroclaw Medical University SUBZ.D260.25.027
6 · The paper itself

Abstract

Melanoma is an aggressive malignancy with poor prognosis in advanced stages, and current therapeutic options provide only limited benefits, highlighting the need for novel treatments. Chetomin, a fungal metabolite isolated from

Indexed as

Antineoplastic AgentsApoptosisCell ProliferationIndole AlkaloidsMelanomaCell Line, TumorCell SurvivalChaetomiumHumansPoly (ADP-Ribose) Polymerase-1Antineoplastic AgentsIndole AlkaloidsPoly (ADP-Ribose) Polymerase-1A375 cellsapoptosiscell proliferationchetominfungal metabolitemelanomanatural product

Identifiers

PMID41097100
PMCPMC12525530

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.